Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 85%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
15,064
Total Claims
$1.3M
Drug Cost
423
Beneficiaries
$3,086
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+124%
Opioid rate vs peers
5.8% vs 2.6% avg
+189%
Cost per patient vs peers
$3,086 vs $1,068 avg
+40%
Brand preference vs peers
12.6% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
5.8%
Opioid Rate
871
Opioid Claims
$51K
Opioid Cost
17.5%
Long-Acting Rate
Brand vs Generic
Brand: 1,886 claims · $1.0M
Generic: 13,057 claims · $273K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 150 | $91K |
| Semaglutide | 66 | $79K |
| Mirabegron | 80 | $49K |
| Dulaglutide | 32 | $34K |
| Linaclotide | 54 | $33K |
| Dapagliflozin Propanediol | 36 | $33K |
| Insulin Glargine,hum.Rec.Anlog | 32 | $33K |
| Insulin Lispro | 30 | $32K |
| Semaglutide | 26 | $28K |
| Sitagliptin Phosphate | 37 | $28K |
| Insulin Degludec | 31 | $28K |
| Fluticasone/Umeclidin/Vilanter | 39 | $27K |
| Empagliflozin | 31 | $26K |
| Insulin Glargine/Lixisenatide | 22 | $25K |
| Cariprazine Hcl | 16 | $24K |
Prescribing Profile
Patient Profile
72
Avg Age
66%
Female
1.48
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About